CORE--MOLECULAR BIOLOGY
核心--分子生物学
基本信息
- 批准号:6590002
- 负责人:
- 金额:$ 7.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Description: The overall goal of the Molecular Biology Facility Core is to
provide Center investigators access to sophisticated and state of the art
molecular techniques. This goal has and will be accomplished through the
following specific aims: 1) Provide both routine and specialized molecular
biology services, currently including DNA isolation, PCR, subcloning, DNA
sequencing, genotyping, and mutation detection. 2) Provide instruction and
assistance in the use of imaging acquisition and analysis instruments,
sequence data analysis, and sequence database searching, as well as provide
supervised access to high throughput sequencing, DNA fragment analysis and
robotics. 3) Provide expertise and consultation for a variety of molecular
biology methodologies. 4) Identify, develop and implement new technologies to
meet the needs of Center investigators. This Facility Core has been used by a
number of Center members during the current funding period. Through a
supplement to the Center grant, they were able to upgrade from a manual
sequencing operation to an automated facility with the purchase of an ABI 377
sequencer. They also have expanded their PCR-based genotyping services. New
computer workstations have been obtained for sequence analysis and several new
imaging instruments have been added to the core, including a Kodak Image
Station 440CF, a Molecular Dynamics FluorImager SI, and a Molecular Dynamics
Storm 820 Phosphoimager. Most recently, this core has moved into expanded and
newly renovated space that provides for an imaging laboratory, a wet
laboratory, and a high throughput/automation laboratory. Future directions
include expanded automation and genotyping services, as well as working
closely with the proposed Functional Genomics Facility Core in the development
of gene expression services and DNA sequencing.
描述:分子生物学设施核心的总体目标是
为中心调查人员访问精致和现状
分子技术。这个目标已经并且将通过
以下特定目的:1)提供常规和专业分子
生物学服务,目前包括DNA隔离,PCR,亚克隆,DNA
测序,基因分型和突变检测。 2)提供指导和
帮助使用成像采集和分析工具,
序列数据分析和序列数据库搜索,并提供
监督访问高吞吐量测序,DNA碎片分析和
机器人技术。 3)提供各种分子的专业知识和咨询
生物学方法论。 4)确定,开发和实施新技术
满足中心调查人员的需求。该设施核心已被一个
当前资金期间的中心成员数量。通过一个
补充中心赠款,他们能够从手册中升级
购买ABI 377的测序操作到自动化设施
音序器。他们还扩展了基于PCR的基因分型服务。新的
已经获得了计算机工作站进行序列分析和几个新的
成像仪器已添加到核心,包括柯达图像
站440CF,一个分子动力学荧光灯SI和分子动力学
风暴820磷酸化剂。最近,这个核心已进入扩展和
新装修的空间可提供成像实验室,湿
实验室和高吞吐量/自动化实验室。未来的方向
包括扩展的自动化和基因分型服务以及工作
与拟议的功能基因组学设施核心紧密
基因表达服务和DNA测序。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianjun Shen其他文献
Jianjun Shen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianjun Shen', 18)}}的其他基金
相似海外基金
The Human Disease Ontology: An integrated, mechanistic knowledge resource for biomedical research.
人类疾病本体论:生物医学研究的综合机械知识资源。
- 批准号:
10697379 - 财政年份:2022
- 资助金额:
$ 7.35万 - 项目类别:
Engineered Mouse Sentinel System for Monitoring Animal Facilities
用于监测动物设施的工程小鼠哨兵系统
- 批准号:
10323482 - 财政年份:2021
- 资助金额:
$ 7.35万 - 项目类别:
Defining malignant hematopoiesis via single-cell multi-omics
通过单细胞多组学定义恶性造血
- 批准号:
10481843 - 财政年份:2020
- 资助金额:
$ 7.35万 - 项目类别:
Defining malignant hematopoiesis via single-cell multi-omics
通过单细胞多组学定义恶性造血
- 批准号:
10018257 - 财政年份:2020
- 资助金额:
$ 7.35万 - 项目类别:
Defining malignant hematopoiesis via single-cell multi-omics - DP5 diversity supplement application
通过单细胞多组学定义恶性造血 - DP5 多样性补充应用
- 批准号:
10658273 - 财政年份:2020
- 资助金额:
$ 7.35万 - 项目类别: